Close Menu


NEW YORK (GenomeWeb News) – Fluxion Biosciences today said that it has signed a reagent supply and collaboration agreement with Rubicon Genomics aimed at circulating tumor cell applications.

NEW YORK (GenomeWeb News) – Transgenomic said in a document filed with the US Securities and Exchange Commission this week that its shareholders have approved an increase in the number of authorized shares of the firm's common stock from 100 million to 150 million.

Cellectricon has resumed an IP infringement suit it initially filed against Fluxion last summer.

The cell-analysis toolmaker inked agreements with distributors in Korea and Japan, and sold its first instrument in China.

The firm will use the Phase II grant to develop a high-throughput screening system.

The firm will use the funding to develop its microfluidic system for cancer diagnostics.

The Italian company will distribute the BioFlux platform in parts of Europe, the Mediterranean, and in North Africa.

New Products: Feb 27, 2009


Thermo Fisher Scientific, Promega, MatriCal Bioscience, Fluxion Biosciences


A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.